SLC41A1 and Parkinson disease: The treatment of SH-SY5Y cells, a widely used cell line in PD research because of its proximity to dopaminergic neurons, with 6-OHDA led to a decrease in the cells’ viability and expression of SLC41A1, NIPA1, MAGT1, and CNNM2.